In their defense, the company and CEO can only deal with the facts as they are. I think even the most ignorant ones here have understood by now that MSE sales have not been as expected. I learnt from CN (yes, i sometimes do (; ) that these kind of products are choosen when standing before the products in the shop. The MS name could therefore have brought in huge sales as it has done for other products. For some reason it didn't work out with the pills, a fact we and the company can only acknowledge. Customers have the final say, ever.
Maybe they should have spent more on publicity, but succes would not have been guaranteed and the company would have spent more money.
In Q3 statement we have seen they continued with cutting costs, as they had already done in Q2.
With CBD they might hit the jackpot by bringing the right product at the right time. Let's hope they do
